Profile of Chronic Non-Epilepsy Drug Use in Children with Epilepsy: Single Centre Experience

Mehul Suthar,Devendra Mishra,Monica Juneja,Bhupinder Singh Kalra,Yajika Arya
DOI: https://doi.org/10.1007/s13312-024-3258-1
2024-09-01
Indian Pediatrics
Abstract:We determined the burden of concomitant chronic non-epilepsy drug use in 100 consecutive outpatient children with a diagnosis of epilepsy (mean (SD) age 7.38 (3.24) y), taking anti-seizure medications (ASM) for at least 6 months. Majority ( n = 68) of the children had comorbidities; most commonly global developmental delay (27%). 61 children were receiving chronic non-epilepsy drugs; most common being calcium (38%), multivitamins (18%) and folic acid (16%). Of these, 50 children (82%) were prescribed drugs without any documented indication. Another 24 children (39.4%) were using complementary and alternative medications. The observed chronic non-epilepsy drug use, many of which were not indicated, reiterates the need to limit the burden of medications in children with epilepsy.
pediatrics
What problem does this paper attempt to address?